Who are Protagenic Therapeutics, Inc.'s main suppliers?

Protagenic Therapeutics, Inc. (PTIX) key suppliers include: PHYTANIX-BIO, UNIVERSITY, Johnson & Johnson, Johnson & Johnson. View the full supplier network at chainsifter.com/chain/PTIX.

What sector is Protagenic Therapeutics, Inc. in?

Protagenic Therapeutics, Inc. (PTIX) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

PTIX Supply Chain: Protagenic Therapeutics, Inc. Supplier List & 7 Relationships

4Suppliers

0Customers

3Debt Items

20Related Chains

Protagenic Therapeutics, Inc. Suppliers

Ticker	Name	Confidence	Evidence
PHYTANIX-BIO	PHYTANIX-BIO	92%	PTIX agreed to pay Phytanix Bio $300,000 at Closing and an additional $10,000 following receipt of specified financial information, in accordance with the terms of the Unwind Agreement.
UNIVERSITY	UNIVERSITY	92%	On July 31, 2005, the Company had entered into a Technology License Agreement with the University pursuant to which the University agreed to license to the Company patent rights and other intellectua…
JNJ	Johnson & Johnson	72%	ats and non-human primates. The doses tested were substantially above the anticipated clinical doses and were well tolerated and safe, with no dose-limiting toxicities observed at doses at least 50-f…
JNJ	Johnson & Johnson	72%	Reciprocal relationship from JNJ graph: Reciprocal relationship from PTIX graph: ats and non-human primates. The doses tested were substantially above the anticipated clinical doses and were well tol…

Protagenic Therapeutics, Inc. Customers

No clients on recordNo downstream customers found in our database for Protagenic Therapeutics, Inc..

Protagenic Therapeutics, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
PTIX-DEBT-11936	Warrants outstanding: 81600	90%	xbrl warrant detail from xbrl 2025-12-31.
PTIX-DEBT	Debt stack $4.0M	90%	Market cache reports total debt of $4.0M.
PTIX-DEBT-11937	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2023-12-31.

Protagenic Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Protagenic Therapeutics, Inc..

Protagenic Therapeutics, Inc. Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for Protagenic Therapeutics, Inc..

Protagenic Therapeutics, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
BDX	Becton, Dickinson and Company	100.00	2
JNJ	Johnson & Johnson	100.00	1	['supplier']
MDT	Medtronic plc	100.00	2
BLLN	BillionToOne, Inc.	50.00	2
CYTOF	Altamira Therapeutics Ltd.	50.00	2
ANIK	Anika Therapeutics, Inc.	50.00	2
CVRX	CVRx, Inc.	50.00	2
AVBP	ArriVent BioPharma, Inc.	50.00	2
ATRA	Atara Biotherapeutics, Inc.	50.00	2
CBIH	Cannabis Bioscience International Holdings, Inc.	50.00	2
BNR	Burning Rock Biotech Limited	50.00	2
BNRG	Brenmiller Energy Ltd	50.00	2
AVTX	Avalo Therapeutics, Inc.	50.00	2
CSTE	Caesarstone Ltd.	50.00	2
SNNUF	Smith & Nephew plc	50.00	2
DYAI	Dyadic International, Inc.	50.00	2
SI	Shoulder Innovations, Inc.	50.00	2
ALC	Alcon Inc.	50.00	2
AORT	Artivion, Inc.	50.00	2
CYCN	Cyclerion Therapeutics, Inc.	50.00	2

Protagenic Therapeutics, Inc. Supply Chain